7 results
P
hospital teams
I/C
Quality Improvement (QI) processes
O
increasing adherence to safe infant sleep recommendations
P
E2F4, FOXM1, TFDP1, E2F1, SIN3A, JUN, DDX4, FOSL1, NOC2L, HMGA1, CDK1, CCNB1, AURKA, CDC20, CCNA2, SCNN1A, CDCA3, SOX6
I/C
O
survival prognosis, immune infiltrations, diagnostic efficacy
P
older adults
I/C
progressive resistance training (PRT), no intervention
O
physical function (PF)
P
Orthodontic-surgical treatment patients
I/C
Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments
O
Oral health-related quality of life
P
8050 patients
I/C
Cyclosporine + methotrexate + Anti-T cell globulin (ATG), tacrolimus + methotrexate + ATG, tacrolimus + bortezomib + sirolimus, cyclosporine + marrow mesenchymal stem cells (MMSCs), corticosteroids alone
O
proportion of patients who respond to therapies
P
children with primary nephrotic syndrome
I/C
traditional Chinese medicine (TCM) granules associated with hormones, no intervention
O
infection rate, recurrence rate, adverse reaction rate
P
Licorice
I/C
Licorice extract, Active compounds, No treatment
O
Declining histological score, Colonic shortness, TNF-α level, Inflammatory response, Anti-inflammation, Anti-oxidative stress, Immunomodulatory effect, Microbiota homeostasis